Navitus Renewed as PBM for Wisconsin ETF by Unanimous Vote of Group Insurance Board

February 23, 2016

MADISON, Wis., February 23, 2016 – Navitus Health Solutions, LLC announced today that the State of Wisconsin Department of Employee Trust Funds (ETF) has extended its contract with Navitus for an additional one-year term, which will continue through 2017. ETF administers group health insurance programs on behalf of the Group Insurance Board (GIB) for the state and Wisconsin Public Employers (WPE). Navitus first contracted to provide services to the state and WPE programs in 2004, and has served in that capacity ever since.

The GIB voted unanimously to extend the Navitus contract on the recommendation of Segal Consulting, a leading national benefits consulting firm that works with public sector clients. Segal was retained by the GIB in November 2014 to study the state’s health insurance program and make recommendations for future cost savings.

Benchmarking the performance of ETF’s benefit program against other similar programs, Segal found that ETF’s pharmacy benefit expenses, as a percentage of overall medical plan costs (medical and drug combined), are reasonable compared to other large plan sponsors. In addition, the pharmacy program already incorporates a number of effective measures for cost control and management that address future cost trends for the plan.

Navitus currently provides pharmacy benefit management for approximately 250,700 Wisconsin state and local employees, retirees and their dependents. Throughout the extended contract term with ETF, Navitus will continue to negotiate improved pharmacy network discounts and pharmaceutical manufacturer rebates on covered medications, and to pass through 100 percent of the savings to the state and WPE programs.

Navitus also will continue its commitment to high-touch service excellence and close collaboration with ETF to ensure the highest level of satisfaction and a clinically appropriate, lowest-net-cost approach to pharmacy benefit management.

“We appreciate the collaborative nature of the Navitus team,” said Lisa Ellinger, Director of the Office of Strategic Health Policy, ETF Division of Insurance. “Working together, we have implemented a number of important and effective measures to maintain quality benefits for state employees while keeping our costs down.”

Terry Seligman, Navitus President and CEO said, “This extended contract is further proof that Navitus’ extraordinary savings, transparency, innovation and unmatched customer service are hallmarks of our client relationships.”

About the State of Wisconsin Department of Employee Trust Funds

The State of Wisconsin Department of Employee Trust Funds administers retirement and other benefit programs for more than 500,000 Wisconsin Retirement System (WRS) participants and 1,400 employers. The programs cover state and local government employees and retirees. The mission is to develop and deliver quality benefits and services to members while safeguarding the integrity of the Trust.

About Navitus

Navitus Health Solutions LLC is a full service, URAC-accredited pharmacy benefit management company. As a zero-spread, full pass through pharmacy benefit manager (PBM), Navitus aligns performance with plan sponsors’ benefit goals to deliver comprehensive clinical programs and cost-saving strategies that lower drug trend and promote good member health. Navitus provides its flexible services to government entities, self-funded employers, coalitions, labor organizations, third-party administrators, and health plans, including managed Medicaid and Medicare Part D. For more information about Navitus Health Solutions’ real solutions to the rising cost of health care, visit www.navitus.com or call 877-571-7500.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow